Next, we investigated the expression of p300 and FLT3 in four patient-derived AML samples harboring FLT3-ITD mutation obtained at the time of diagnosis without prior treatment (patient information is provided in Table S3). The gene discussed is EP300; the disease is acute myeloid leukemia.